Drug recall D-0269-2023
Product
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, packaged in (a) 100-count bottle, NDC 68001-501-00; (b) 500-count bottle, NDC 68001-501-03. Manufactured by Alkem Laboratories Ltd., India. For BluePoint Laboratories
Reason for recall
Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.
Lots and codes
Lots: (a) 21143211, EXP 03/31/2023; (b) 21143185, 21143193, EXP 02/28/2023
Recall details
- Recalling firm
- Amerisource Health Services LLC, Columbus, OH
- Quantity
- (a) 6670 100-count (b) 2666 500-count bottles
- Distribution
- Nationwide USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 11, 2023
- Terminated
- May 12, 2024
Related products
- Metoprolol Succinate – drug information
- NDC 68001-501 Metoprolol Succinate · Metoprolol Succinate 50 mg/1 · BluePoint Laboratories
- NDC 68001-503 Metoprolol Succinate · Metoprolol Succinate 200 mg/1 · BluePoint Laboratories
- NDC 68001-502 Metoprolol Succinate · Metoprolol Succinate 100 mg/1 · BluePoint Laboratories
- NDC 68001-500 Metoprolol Succinate · Metoprolol Succinate 25 mg/1 · BluePoint Laboratories